The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Positron Emission Tomography in Determining Stage of Esophageal Cancer
Official Title: The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Carcinoma of the Thoracic Esophagus
Study ID: NCT00004867
Brief Summary: RATIONALE: Imaging procedures such as positron emission tomography may improve the ability to determine the stage of esophageal cancer. PURPOSE: This clinical trial is studying how well fludeoxyglucose F 18 positron emission tomography determines tumor stage in patients with esophageal cancer.
Detailed Description: OBJECTIVES: Primary Objective: To evaluate whether FDG-PET imaging can detect lesions that would preclude surgery (esophagectomy) in patients found to be surgical candidates by standard imaging procedures. Secondary Objective: To use the collected data to generate hypotheses to be used in future studies, such as which types of previously undetected lesions FDG-PET imaging is best able to identify.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States
Mobile Infirmary Medical Center, Mobile, Alabama, United States
University of South Alabama Cancer Research Institute, Mobile, Alabama, United States
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, United States
UCSF Comprehensive Cancer Center, San Francisco, California, United States
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora, Colorado, United States
Morton Plant Hospital, Clearwater, Florida, United States
Indiana University Cancer Center, Indianapolis, Indiana, United States
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
Cancer Center at Greater Baltimore Medical Center, Baltimore, Maryland, United States
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
William Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States
Siteman Cancer Center at Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
SUNY Upstate Medical University Hospital, Syracuse, New York, United States
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
McDowell Cancer Center at Akron General Medical Center, Akron, Ohio, United States
Bethesda North Hospital, Cincinnati, Ohio, United States
Tri-Health Good Samaritan Hospital, Cincinnati, Ohio, United States
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States
Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States
Westmoreland Regional Hospital, Greensburg, Pennsylvania, United States
Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
St. Clair Memorial Hospital, Pittsburgh, Pennsylvania, United States
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States
University of Tennessee, Memphis, Memphis, Tennessee, United States
Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus, Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville, Tennessee, United States
Baylor University Medical Center, Dallas, Texas, United States
LDS Hospital, Salt Lake City, Utah, United States
Massey Cancer Center at Virginia Commonwealth University, Richmond, Virginia, United States
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle, Washington, United States
Name: Bryan F. Meyers, MD, MPH
Affiliation: Washington University Siteman Cancer Center
Role: STUDY_CHAIR